P

Inventor

TACHIKAWA KIYOSHI

US26 patents
⚠️ This page may combine multiple inventors who share the name “TACHIKAWA KIYOSHI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ARCTURUS THERAPEUTICS INC

24 patents
US9856475B2Jan 2, 2018

Formulations for treating amyloidosis

ARCTURUS THERAPEUTICS INC5 citations84
US11744887B2Sep 5, 2023

Coronavirus vaccine compositions and methods

ARCTURUS THERAPEUTICS INC4 citations82
US10369232B2Aug 6, 2019

Allele selective gene editing and uses thereof

ARCTURUS THERAPEUTICS INC14 citations81
US11015204B2May 25, 2021

Synthesis and structure of high potency RNA therapeutics

ARCTURUS THERAPEUTICS INC6 citations80
US10815463B2Oct 27, 2020

Messenger UNA molecules and uses thereof

ARCTURUS THERAPEUTICS INC6 citations73
US10421964B2Sep 24, 2019

UNA oligomers and compositions for treating amyloidosis

ARCTURUS THERAPEUTICS INC2 citations73
US9982259B2May 29, 2018

Transthyretin allele selective UNA oligomers for gene silencing

ARCTURUS THERAPEUTICS INC5 citations73
US11685906B2Jun 27, 2023

Compositions and methods for treating ornithine transcarbamylase deficiency

ARCTURUS THERAPEUTICS INC4 citations72
US12220455B2Feb 11, 2025

Coronavirus vaccine compositions and methods

ARCTURUS THERAPEUTICS INC1 citations71
US11759515B2Sep 19, 2023

Compositions and methods for inducing immune responses

ARCTURUS THERAPEUTICS INC1 citations70
US12290567B2May 6, 2025

Asialoglycoprotein Receptor mediated delivery of therapeutically active conjugates

ARCTURUS THERAPEUTICS INC1 citations61
US12398379B2Aug 26, 2025

Compositions and methods for treating ornithine transcarbamylase deficiency

ARCTURUS THERAPEUTICS INC0 citations60
US12390524B2Aug 19, 2025

Compositions and methods for inducing immune responses

ARCTURUS THERAPEUTICS INC0 citations59
US11939363B2Mar 26, 2024

Translatable molecules and synthesis thereof

ARCTURUS THERAPEUTICS INC0 citations59
US11407800B2Aug 9, 2022

Translatable molecules and synthesis thereof

ARCTURUS THERAPEUTICS INC1 citations59
US12509698B2Dec 30, 2025

Synthesis and structure of high potency RNA therapeutics

ARCTURUS THERAPEUTICS INC0 citations58
US12070509B2Aug 27, 2024

Nucleic acids and methods of treatment for cystic fibrosis

ARCTURUS THERAPEUTICS INC1 citations57
US12351834B2Jul 8, 2025

Compositions and methods for the treatment of ornithine transcarbamylase deficiency

ARCTURUS THERAPEUTICS INC0 citations56
US11939600B2Mar 26, 2024

Compositions and methods for treating phenylketonuria

ARCTURUS THERAPEUTICS INC0 citations53
US10604758B2Mar 31, 2020

Therapeutic oligomers for treating amyloidosis

ARCTURUS THERAPEUTICS INC0 citations52
US10519447B2Dec 31, 2019

Therapeutic UNA oligomers and uses thereof

ARCTURUS THERAPEUTICS INC0 citations52
US11685921B2Jun 27, 2023

Molecules and agents for treating hepatitis B virus

ARCTURUS THERAPEUTICS INC0 citations50
US10961535B2Mar 30, 2021

Compositions and agents against hepatitis B virus and uses thereof

ARCTURUS THERAPEUTICS INC0 citations50
US10683500B2Jun 16, 2020

UNA oligomers having reduced off-target effects in gene silencing

ARCTURUS THERAPEUTICS INC0 citations42

ULTRAGENYX PHARMACEUTICAL INC

1 patent

BRIGGS STEVEN P

1 patent